SurModics, Inc. (SRDX) – Financial and Strategic SWOT Analysis Review

SurModics, Inc. (SRDX) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
54
Medical Devices
United States

SurModics, Inc. (SRDX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SurModics, Inc. (SurModics) is one of the leading providers of drug delivery and in vitro diagnostic technologies. Its core drug delivery technologies and surface modification coating technologies are employed in the development of new medical devices, biomedical products and in the enhancement of existing products and devices. SurModics commercializes its technologies through licensing and royalty arrangements with medical device manufacturers. It sells components for in vitro diagnostic test kits and microarrays; and manufactures and distributes surface coatings to the diagnostic and biomedical research markets. The company also operates as an exclusive North American distributor of Diarect AG for its immunoassay diagnostic products. SurModics is headquartered in Minnesota, the US.

The company focuses on innovation and development of the front-end businesses to differentiate its offerings. It also prioritizes on long-term investments in technology and systems to execute its succession plans. SurModics envisages establishing its position through internal development, strong partner relationships, strategic collaborations and royalty agreements.

SurModics, Inc. Key Recent Developments

Mar 06, 2015: SurModics Announces New Board Chair
Feb 05, 2015: SurModics Announces Gerald B. Fischer’s Retirement from Board of Directors
Jan 29, 2015: SurModics Reports First Quarter Fiscal 2015 Results
Dec 04, 2013: SurModics to Present at Oppenheimer Healthcare Conference
Nov 26, 2013: SurModics to Present at Piper Jaffray Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
SurModics, Inc. – Key Facts 6
SurModics, Inc. – Key Employees 7
SurModics, Inc. – Key Employee Biographies 8
SurModics, Inc. – Major Products and Services 9
SurModics, Inc. – Medical Equipment Pipeline Products Data 10
SurModics, Inc. Pipeline Products by Equipment Type 10
SurModics, Inc. Pipeline Products by Development Stage 11
SurModics, Inc. – History 12
SurModics, Inc. – Company Statement 15
SurModics, Inc. – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 18
SurModics, Inc. – Business Description 18
SurModics, Inc. – Corporate Strategy 19
SurModics, Inc. – SWOT Analysis 20
SWOT Analysis – Overview 20
SurModics, Inc. – Strengths 20
Strength – Medical Device Business Unit 20
Strength – Focused Research & Development 20
Strength – Licensing and Royalty Agreements 20
Strength – Healthy Liquidity Position 20
SurModics, Inc. – Weaknesses 22
Weakness – Declining Performance of In Vitro Diagnostics Business 22
Weakness – Dependence on a Major Customer 22
SurModics, Inc. – Opportunities 23
Opportunity – Global In Vitro Diagnostics Market 23
Opportunity – Growing Clinical Laboratory Testing Industry 23
Opportunity – Product Innovation 23
Opportunity – Marketing Initiatives 23
SurModics, Inc. – Threats 24
Threat – Stiff Competition 24
Threat – Regulatory Requirements 24
Threat – Risk of Product Obsolescence 24
Threat – Single Manufacturing Facility 24
SurModics, Inc. – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
SurModics, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 31
SurModics, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 32
SurModics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 33
SurModics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 34
SurModics, Inc., Recent Deals Summary 35
Section 5 – Company’s Recent Developments 36
Mar 06, 2015: SurModics Announces New Board Chair 36
Feb 05, 2015: SurModics Announces Gerald B. Fischer’s Retirement from Board of Directors 37
Jan 29, 2015: SurModics Reports First Quarter Fiscal 2015 Results 38
Nov 06, 2014: SurModics Reports Fourth Quarter Fiscal 2014 Results 40
Jul 31, 2014: SurModics Reports Third Quarter Fiscal 2014 Results 42
Jun 05, 2014: SurModics Introduces Non-Corrosive, Non-Hazardous TMB Stop Solution 44
May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results 45
Feb 18, 2014: SurModics Announces Changes to Board of Directors 47
Jan 30, 2014: SurModics Reports First Quarter Fiscal 2014 Results 48
Section 6 – Appendix 50
Methodology 50
Ratio Definitions 50
About GlobalData 54
Contact Us 54
Disclaimer 54



List of Tables
SurModics, Inc., Key Facts 6
SurModics, Inc., Key Employees 7
SurModics, Inc., Key Employee Biographies 8
SurModics, Inc., Major Products and Services 9
SurModics, Inc. Number of Pipeline Products by Equipment Type 10
SurModics, Inc. Pipeline Products by Equipment Type 10
SurModics, Inc. Number of Pipeline Products by Development Stage 11
SurModics, Inc. Pipeline Products by Development Stage 11
SurModics, Inc., History 12
SurModics, Inc., Subsidiaries 17
SurModics, Inc., Key Competitors 25
SurModics, Inc., Ratios based on current share price 26
SurModics, Inc., Annual Ratios 27
SurModics, Inc., Interim Ratios 29
SurModics, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 31
SurModics, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 32
SurModics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 33
SurModics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 34
SurModics, Inc., Recent Deals Summary 35
Currency Codes 50
Capital Market Ratios 50
Equity Ratios 51
Profitability Ratios 51
Cost Ratios 52
Liquidity Ratios 52
Leverage Ratios 53
Efficiency Ratios 53



List of Figures
SurModics, Inc. Pipeline Products by Equipment Type 10
SurModics, Inc. Pipeline Products by Development Stage 11
SurModics, Inc., Performance Chart (2010 – 2014) 28
SurModics, Inc., Ratio Charts 30
SurModics, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 31
SurModics, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 32
SurModics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 33
SurModics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 34

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.